Technology Transfer Program Commercial Assessment Leads

The contract aims to provide marketing data to support the FDA Technology Transfer Program, enabling staff to evaluate the market potential of FDA inventions. This effort focuses on helping the agency assess the commercial viability of technologies developed within the FDA, thereby facilitating technology transfer and possibly promoting innovation and public access to these inventions. Issued by the Food and Drug Administration with a classification under NAICS code 541199, the opportunity is listed as a forecast without specific set-aside details or a defined place of performance. Key contacts include an acquisition liaison within the FDA and a yet-to-be-determined contracting officer, indicating that the procurement process is in preliminary stages. The contract’s purpose is central to enhancing the FDA’s capabilities to bring new technologies to market by leveraging commercial assessment expertise.